AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the 2013 RBC Capital Markets’ Healthcare Conference on Wednesday, February 27, 2013 at 2:00 p.m. (ET) in New York City.
A live webcast of AVEO’s presentation can be accessed by visiting the investors section of the company’s website at investor.aveooncology.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation.
AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response PlatformTM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveooncology.com.
Monique Allaire, 617-299-5810
Rob Kloppenburg, 617-930-5595
|Hi-Tech Pharmacal to Present at the 2013 RBC Capital Markets’ Healthcare Conference (2013/2/26)|
|Warner Chilcott to Present at the 2013 RBC Capital Markets Healthcare Conference (2013/2/22)|
|Brookdale to Present at 2013 RBC Capital Markets Healthcare Conference on February 26 (2013/2/22)|
|Boston Scientific To Participate In 2013 RBC Capital Markets Healthcare Conference (2013/2/21)|
|Greatbatch, Inc. to Participate in the 2013 RBC Capital Markets Healthcare Conference (2013/2/22)|
|Antares Pharma to Participate in the 2013 RBC Capital Markets’ Healthcare Conference (2013/2/20)|
|ARIAD To Present at The RBC Capital Markets Healthcare Conference (2013/2/19)|
|NPS Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference (2013/2/19)|
|Chemed Corporation to Present at the RBC Capital Markets’ Healthcare Conference (2013/2/21)|
|Spectrum Pharmaceuticals to Present Corporate Update at the RBC Capital Markets Healthcare Conference in New York on February 27th (2013/2/20)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.